Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
187 hedge funds and large institutions have $2.92B invested in Axonics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 71 increasing their positions, 60 reducing their positions, and 23 closing their positions.
48% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 23
18% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 60
6% more funds holding
Funds holding: 177 → 187 (+10)
4% more capital invested
Capital invested by funds: $2.79B → $2.92B (+$122M)
33% less call options, than puts
Call options by funds: $5.87M | Put options by funds: $8.75M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$71.3M |
| 2 |
Goldman Sachs
New York
|
+$33.3M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$28.3M |
| 4 |
BlackRock
New York
|
+$27.6M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$27.5M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$71.1M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$27.1M |
| 3 |
AC
Armistice Capital
New York
|
-$24M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$21.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$20.6M |
AXNX Hedge Fund Activity: Q3 2021 in Review
187 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q3 2021, worth a combined $2.92B — up 4.4% from $2.79B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new AXNX positions and 23 closed out — a net gain of 11 holders — while 71 added to existing stakes and 60 trimmed.
The largest buyer was Vanguard Group, adding an estimated $71.3M. The largest seller was Millennium Management, cutting an estimated $71.1M.
- 187 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q3 2021, up from 177 in Q2 2021.
- Funds reported $2.92B of Axonics, Inc. Common Stock stock for Q3 2021, up 4.4% quarter-over-quarter.
- 34 funds opened new Axonics, Inc. Common Stock positions in Q3 2021 and 23 closed out, a net change of +11 holders.
- The largest Axonics, Inc. Common Stock buyer in Q3 2021 was Vanguard Group, an estimated $71.3M added.
- The largest Axonics, Inc. Common Stock seller in Q3 2021 was Millennium Management, an estimated $71.1M sold.
Based on aggregated 13F filings for Q3 2021.